JP2014526266A5 - - Google Patents

Download PDF

Info

Publication number
JP2014526266A5
JP2014526266A5 JP2014531242A JP2014531242A JP2014526266A5 JP 2014526266 A5 JP2014526266 A5 JP 2014526266A5 JP 2014531242 A JP2014531242 A JP 2014531242A JP 2014531242 A JP2014531242 A JP 2014531242A JP 2014526266 A5 JP2014526266 A5 JP 2014526266A5
Authority
JP
Japan
Prior art keywords
gram
composition
positive bacterium
trehalose
positive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014531242A
Other languages
English (en)
Japanese (ja)
Other versions
JP6117212B2 (ja
JP2014526266A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2012/068633 external-priority patent/WO2013041672A1/en
Publication of JP2014526266A publication Critical patent/JP2014526266A/ja
Publication of JP2014526266A5 publication Critical patent/JP2014526266A5/ja
Application granted granted Critical
Publication of JP6117212B2 publication Critical patent/JP6117212B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014531242A 2011-09-23 2012-09-21 改変されたグラム陽性菌及びその使用 Expired - Fee Related JP6117212B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11182642 2011-09-23
EP11182642.6 2011-09-23
PCT/EP2012/068633 WO2013041672A1 (en) 2011-09-23 2012-09-21 Modified gram positive bacteria and uses thereof

Publications (3)

Publication Number Publication Date
JP2014526266A JP2014526266A (ja) 2014-10-06
JP2014526266A5 true JP2014526266A5 (cg-RX-API-DMAC7.html) 2016-06-30
JP6117212B2 JP6117212B2 (ja) 2017-04-19

Family

ID=47022630

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014531242A Expired - Fee Related JP6117212B2 (ja) 2011-09-23 2012-09-21 改変されたグラム陽性菌及びその使用

Country Status (7)

Country Link
US (2) US9458467B2 (cg-RX-API-DMAC7.html)
EP (1) EP2758512B1 (cg-RX-API-DMAC7.html)
JP (1) JP6117212B2 (cg-RX-API-DMAC7.html)
DK (1) DK2758512T3 (cg-RX-API-DMAC7.html)
ES (1) ES2676707T3 (cg-RX-API-DMAC7.html)
HU (1) HUE038830T2 (cg-RX-API-DMAC7.html)
WO (1) WO2013041672A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2653757C2 (ru) * 2011-09-23 2018-05-14 Интрексон Актобиотикс Н.В. Модифицированные грамположительные бактерии и их применение
ES3048233T3 (en) 2014-12-23 2025-12-09 Ilya Pharma Ab Methods for wound healing
CA3035151A1 (en) * 2016-09-02 2018-03-08 Intrexon Actobiotics N.V. Genetically modified bacteria stably expressing il-10 and insulin
IL265177B2 (en) 2016-09-13 2025-01-01 Intrexon Actobiotics N V A microorganism that adheres to the mucosa
CN108410763B (zh) * 2018-03-14 2020-10-09 绍兴同创生物科技有限公司 长双歧杆菌tc01及其应用和应用其的产品
CN113481207B (zh) * 2021-07-15 2023-04-07 西南大学 家蚕卵滞育的必需基因Bmtret1及其应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9006400D0 (en) 1990-03-22 1990-05-23 Ciba Geigy Ag Bacterial vectors
US6277969B1 (en) 1991-03-18 2001-08-21 New York University Anti-TNF antibodies and peptides of human tumor necrosis factor
IT1270123B (it) 1994-10-05 1997-04-28 Dompe Spa Composizioni farmaceutiche contenenti microorganismi ingegnerizzati e loro uso per terapia
GB9521568D0 (en) 1995-10-20 1995-12-20 Lynxvale Ltd Delivery of biologically active polypeptides
US6033376A (en) 1998-09-30 2000-03-07 Allergan Sales, Inc. Wound shaper sleeve
CA2343840C (en) 1998-10-20 2011-03-08 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Use of a cytokine-producing lactococcus strain to treat colitis
ES2272311T3 (es) 1999-07-05 2007-05-01 Vlaams Interuniversitair Instituut Voor Biotechnologie Suministro de peptidos trebol.
AT407730B (de) 2000-01-14 2001-05-25 Hoerbiger Hydraulik Betätigungsanordnung für schwenkbare teile an fahrzeugen
GB0013810D0 (en) 2000-06-06 2000-07-26 Celltech Chiroscience Ltd Biological products
AU2002314040B2 (en) 2001-05-03 2007-06-28 Intrexon Actobiotics Nv Self-containing lactococcus strain
AU2003298291A1 (en) 2002-11-15 2004-06-15 Universiteit Gent Self-containing lactobacillus strain
CA2557496C (en) 2004-02-24 2016-12-06 Chr. Hansen A/S Frozen lactic acid bacterial culture of individual pellets
BRPI0511261A (pt) 2004-05-18 2007-11-27 Vib Vzw linhagem isolada de lactobacillus sp., uso de uma linhagem isolada de lactobacillus sp., e composição farmacêutica
US9200249B2 (en) 2004-08-20 2015-12-01 Actogenix N.V. Method to improve Lactococcus preservation
AU2006286563B2 (en) 2005-08-30 2012-02-23 Intrexon Actobiotics Nv Anti-TNF alpha producing lactic acid bacteria for the treatment of chronic enterocolitis
US8748126B2 (en) 2005-11-29 2014-06-10 Actogenix N.V. Induction of mucosal tolerance to antigens
RU2008147398A (ru) 2006-05-02 2010-06-10 Актогеникс Н.В. (Be) Доставка пептидов, связанных с ожирением, через кишечник посредством микроорганизмов
EP2097452A1 (en) 2006-12-14 2009-09-09 Actogenix N.V. Delivery of binding molecules to induce immunomodulation
CN101605900B (zh) 2007-01-12 2014-04-23 阿克图杰尼斯公司 乳球菌启动子和其用途
EP2125010B1 (en) 2007-01-25 2014-06-04 Actogenix N.V. Treatment of immune disease by mucosal delivery of antigens using genetically modified lactobacillus
WO2010034844A1 (en) 2008-09-29 2010-04-01 Actogenix N.V. Reduced colonization of microbes at the mucosa
DK2424972T3 (da) 2009-04-30 2013-10-14 Actogenix Nv Kryobeskyttende midler til frysetørring af mælkesyrebakterier
RU2653757C2 (ru) * 2011-09-23 2018-05-14 Интрексон Актобиотикс Н.В. Модифицированные грамположительные бактерии и их применение

Similar Documents

Publication Publication Date Title
JP2014527826A5 (cg-RX-API-DMAC7.html)
CN103620021B (zh) 新型组合物
JP2014526266A5 (cg-RX-API-DMAC7.html)
RU2014116230A (ru) Модифицированные грамположительные бактерии и их применение
JP5727611B2 (ja) 生体物質用の乾燥貯蔵安定化組成物
Pinto et al. Influence of microencapsulation with sweet whey and prebiotics on the survival of Bifidobacterium-BB-12 under simulated gastrointestinal conditions and heat treatments
JP6889699B2 (ja) 特定栄養用途のための安定乾燥プロバイオティクス組成物
CN103004984B (zh) 一种植物乳杆菌发酵乳及其制备方法
CN102482635B (zh) 具有增强稳定性和生存力的包被的脱水微生物
RU2014151746A (ru) Штаммы lactobacillus
CN102965321A (zh) 一种复合乳酸菌冻干粉的制备方法
CN108368474A (zh) 没有或几乎没有糖的稳定的干组合物
KR20200001543A (ko) 구연산염을 포함하는 유산균 동결 보호용 조성물
CN108271382A (zh) 微生物干燥菌体的制造方法
CN102329759B (zh) 一种提高嗜酸乳杆菌冻干存活率的方法
Upadrasta et al. Improving the stress tolerance of probiotic cultures: recent trends and future directions
KR20060131854A (ko) 개별 펠릿의 냉동 유산균 컬쳐
Kriger et al. Properties of lactic acid microorganisms: long-term preservation methods.
Lee et al. Isolation of Lactobacillus plantarum from kimchi and its inhibitory activity on the adherence and growth of Helicobacter pylori
CN103184183A (zh) 一种干酪乳杆菌干粉的制备方法
JP6074799B2 (ja) 乳酸菌増殖促進剤及びこれを含有するヨーグルト
Santivarangkna Storage Stability of Probiotic Powder
KR101764095B1 (ko) 유산균 분말의 제조방법
Urbański et al. Influence of whey on viability of Lactobacillus gasseri during freeze-drying process
CN103525704A (zh) 一种提高乳酸菌冻干存活率的方法